Vast Therapeutics Announces Results Showing Ability to Eradicate Anthrax
BIOC51 Antimicrobial Activity against Bacillus anthracis (Anthrax), Adding to the List of Bacteria Susceptible to the Company’s Drug Candidate |
Vast Therapeutics Announces Results Showing Ability to Eradicate Anthrax
BIOC51 Antimicrobial Activity against Bacillus anthracis (Anthrax), Adding to the List of Bacteria Susceptible to the Company’s Drug Candidate |
AddressContact Us
|
|